Comments
Loading...

Innate Pharma

IPHANASDAQ
$2.18
0.020.93%
Pre-Market: Jul 18, 8:39 AM EDT
15 minutes delayed

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
0
0
0
0
Mar
0
0
0
0
Apr
0
0
0
0
May
0
0
0
0
Jun
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About Innate Pharma
Sector
Health Care
Industry
Biotechnology
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherap...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
IPHA
SYRS

FAQ

Q

How do I buy Innate Pharma (IPHA) stock?

A

You can purchase shares of Innate Pharma (NASDAQ:IPHA) through any online brokerage.

View our list of the best stock brokerages

Q

What is the target price for Innate Pharma (IPHA) stock?

A

There is no analysis for Innate Pharma.

Q

What is the forecast for Innate Pharma (IPHA) stock?

A

Innate Pharma has a consensus price target of $10.83.

Q

Current stock price for Innate Pharma (IPHA)?

A

The stock price for Innate Pharma (NASDAQ: IPHA) is $2.15 last updated July 19, 2024 at 3:59 PM EDT.

Q

Does Innate Pharma (IPHA) pay a dividend?

A

There are no upcoming dividends for Innate Pharma.

Q

When is Innate Pharma (NASDAQ:IPHA) reporting earnings?

A

Innate Pharma’s H1 earnings are confirmed for Thursday, September 12, 2024.

Q

Is Innate Pharma (IPHA) going to split?

A

There is no upcoming split for Innate Pharma.

Q

What sector and industry does Innate Pharma (IPHA) operate in?

A

Innate Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch